Humoral Immunogenicity and Reactogenicity of the Standard ChAdOx1 nCoV-19 Vaccination in Taiwan

Background: The ChAdOx1 nCoV-19 vaccine has been widely administered against SARS-CoV-2 infection; however, data regarding its immunogenicity, reactogenicity, and potential differences in responses among Asian populations remain scarce. Methods: 270 participants without prior COVID-19 were enrolled...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Jer-Hwa, Chiou, Jeng-Fong, Hung, Ching-Sheng, Liu, Ming-Che, Chang, Hui-Wen, Hong, Shiao-Ya, Wang, Cheng-Yi, Lin, Yi-Ling, Hsieh, Yi-Chen, Chung, Chi-Li, Su, Ying-Shih, Hsiao, Shu-Tai Shen, Liu, Doresses, Liang, Jian-Jong, Liao, Chun-Che, Chang, Chih-Shin, Lai, Kevin Shu-Leung, Chuang, Han-Chuan, Chien, Ko-Ling, Wu, Wei-Ciao, Lee, Yuan-Chii G., Lin, Sey-En, Shen, Yung-Kang, Hsu, Chiung-Fang, Wang, Jude Chu-Chun, Hsiao, Shih-Hsin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874464/
https://www.ncbi.nlm.nih.gov/pubmed/35214770
http://dx.doi.org/10.3390/vaccines10020312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874464/
https://www.ncbi.nlm.nih.gov/pubmed/35214770
http://dx.doi.org/10.3390/vaccines10020312

Ejemplares similares